Insider Transactions

What ProQR Therapeutics N.V.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	5	5
Sells	0	0
Total trades	5	5

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

Common stock only — 5 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
de Boer Daniel Anton	Chief Executive Officer	Jul 31	Open-market buy · P	+200,000	$1.77	+$354K	500,000
Filius Bart	Director	Jul 17	Open-market buy · P	+150,000	$1.72	+$258K	300,000
de Boer Daniel Anton	Chief Executive Officer	Jul 09	Open-market buy · P	+150,000	$1.74	+$261K	300,000
de Boer Daniel Anton	Chief Executive Officer	Jul 07	Open-market buy · P	+150,000	$1.59	+$239K	150,000
Filius Bart	Director	Jun 26	Open-market buy · P	+150,000	$1.54	+$231K	150,000

Page 1 of 1 · showing the 5 most recent Sign up free to view all 5 transactions and filter by insider →